[Iatrogenic botulism in therapeutic use of botulinum toxin].
Ugeskr Laeger
; 184(7)2022 02 14.
Article
em Da
| MEDLINE
| ID: mdl-35179113
The review summarises the current knowledge of the treatment of iatrogenic botulinum toxin overdose. The symptoms may be diffuse, and suspicion should be raised based on time of symptom appearance relative to the time of exposure. Iatrogenic botulism may appear if the maximum recommended total dose of botulinum toxin has been exceeded and if the drug is spread locally from the site of injection or is redistributed to the systemic circulation. The adverse drug reactions frequency is possibly underreported. Fast initiation of the available antidote may be needed. The guideline provided on treatment of iatrogenic botulism is developed from non-iatrogenic botulism.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Botulismo
/
Toxinas Botulínicas Tipo A
Tipo de estudo:
Diagnostic_studies
/
Guideline
Limite:
Humans
Idioma:
Da
Revista:
Ugeskr Laeger
Ano de publicação:
2022
Tipo de documento:
Article